{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers HK | Online Trading in stocks, bonds & ETFS","description":"Discover Tiger Brokers HK, an online trading platform for stocks&ETFs, options&futures, bonds and crypto. Open an account to enjoy low commission trading today!","keywords":"tiger trading,tiger security,tiger broker hk,tigers co ltd,tiger trade hk,tiger brokers hk,stock broker,securities broker,online brokerage,hong kong broker,hk broker,online stock trading,online trading platform,stock trading platforms,trading application,stock trading,stock trading hong kong,buying stocks in hong kong,tiger brokers","social":{"ogDescription":"Discover Tiger Brokers HK, an online trading platform for stocks&ETFs, options&futures, bonds and crypto. Open an account to enjoy low commission trading today!","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.be62fbe1.png","ogUrl":"https://www.tigerhkgo.com/stock/PAB.AU"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"HKG","license":"TBHK","edition":"fundamental","symbol":"PAB.AU"},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"PAB.AU\",,,,,undefined,":{"symbol":"PAB.AU","market":"AU","secType":"STK","nameCN":"PATRYS LTD","latestPrice":0.002,"timestamp":1741583520000,"preClose":0.002,"halted":0,"volume":618016,"delay":0,"changeRate":0,"change":0,"floatShares":1390623715,"shares":2057447335,"eps":-0.001504,"lyrEps":-0.001721,"pbRate":2.09,"amount":1236,"amplitude":0,"volumeRatio":4.138919,"dividePrice":0,"prevYearClose":0.004,"fiveDayClose":0.002,"twentyDayClose":0.002},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"PAB.AU\",,,,,undefined,":{"symbol":"PAB.AU","floatShares":1390623715,"roa":"-43.37%","roe":"-88.89%","lyrEps":-0.001721,"volumeRatio":4.138919,"shares":2057447335,"dividePrice":0,"high":0.002,"amplitude":0,"preClose":0.002,"low":0.002,"week52Low":0.002,"pbRate":"2.09","psRate":"2.83","week52High":0.01,"institutionHeld":0,"latestPrice":0.002,"committee":0.466037,"eps":-0.001504,"divideRate":0,"volume":618016,"delay":0,"ttmEps":-0.001504,"open":0.002,"prevYearClose":0.004,"prevWeekClose":0.002,"prevMonthClose":0.003,"prevQuarterClose":0.004,"fiveDayClose":0.002,"twentyDayClose":0.002,"sixtyDayClose":0.004},"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/PAB.AU\",params:#limit:5,,,undefined,":[{"market":"AU","date":"2021-11-03","symbol":"PAB.AU","defaultRemindTime":1635894000000,"type":"split","dateTimestamp":1635858000000,"forFactor":995841,"toFactor":1000000,"ratio":0.9958410000000001},{"market":"AU","date":"2020-11-11","symbol":"PAB.AU","type":"split","dateTimestamp":1605013200000,"forFactor":2147483647,"toFactor":2147483647,"ratio":0.99319}],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"PAB.AU\",market:\"AU\",,,undefined,":[],"@#url:\"https://hq.skytigris.cn/market/plate/belongs/PAB.AU\",params:#limit:6,delay:false,,,undefined,":[{"market":"AU","name":"Pharmaceutical Companies","bkCode":"BK7508","id":"package_au_concept_yyswg","changeRate":-0.014999}],"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"PAB.AU\",pageSize:4,pageCount:1,lang_content:\"en\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"2472559958","title":"BUZZ-Australia's Patrys slumps to record low as cancer antibody fails production parameters","url":"https://stock-news.laohu8.com/highlight/detail?id=2472559958","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2472559958?lang=en_us&edition=fundamental","pubTime":"2024-10-02 14:04","pubTimestamp":1727849046,"startTime":"0","endTime":"0","summary":"** Shares of biotech firm Patrys    fall 50% to A$0.003, a record low   ** Stock posts biggest intraday pct fall since Nov. 11, 2008   ** Co says cancer therapy antibody PAT-DX1 did not pass some parameters in production    ** Adds, it will not use the produced batch for planned Phase-1 clinical trial in cancer patients   ** Says it will now pivot towards developing therapeutic possibilities for its other antibody, PAT-DX3   ** About 24 mln shares change hands, ~28x the 30-day avg volume   ** PNB down ~63% YTD ","market":null,"thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.rkd.refinitiv.com/api/News/News.svc/REST/News_1/RetrieveStoryML_1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK7067","XAO.AU","XJO.AU","XKO.AU","BK7508","PAB.AU"],"gpt_icon":0}],"pageSize":4,"totalPage":1,"pageCount":1,"totalSize":1}]}}